Combining Precision Cancer Medicine with Digital Health for Breakthrough Discoveries and Improved Treatments

Introduction

iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.

iCAN News

iCAN in Numbers

iCAN Study Participants

Company collaborations

iCAN Publications

Invention
Disclosures

Patents

External Funding

Key Stakeholders